Immune defective states in tumor patients
Schumacher, K.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 418-427
1980
ISSN/ISBN: 0070-4067 PMID: 7223034 Document Number: 166469
Document emailed within 1 workday
Related Documents
Zeitz, M. 1990: Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2 Zeitschrift für Gastroenterologie 28(3): 179-180Shi, L.; Chen, J.; Zhong, Q.; Geng, P.; He, J. 2014: Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice Zhonghua Zhong Liu Za Zhi 36(3): 177-182
Hoshino, T.; Jiang, Y.Z.; Dunn, D.; Paul, D.; Qazilbash, M.; Cowan, K.; Wang, J.; Barrett, J.; Liu, J. 1998: Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination Cancer Gene Therapy 5(3): 150-157
Mohagheghpour, N.; Gelber, R.H.; Larrick, J.W.; Sasaki, D.T.; Brennan, P.J.; Engleman, E.G. 1985: Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2 Journal of Immunology 135(2): 1443-1449
Jeffery, H.; Cunningham, R.A.; Cubis, A.; Read, D.J. 1981: New methods to separate artifacts from normal and defective breathing patterns in different sleep-states, if infants are monitored at home Australian and New Zealand Journal of Medicine 11(4): 406-411
Li, W.; Zhang, Y.; Wang, S. 2001: Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(1): 61-65
Stein, G.; Henn, W.; von Laue, H.; Berg, P. 1998: Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy European Journal of Medical Research 3(4): 194-202
Hakim, A.A. 1984: Carcinoembryonic antigen, a tumor-associated glycoprotein induces defective lymphocyte function Neoplasma 31(4): 385-397
Springer, G.F.; Desai, P.R.; Fry, W.A.; Goodale, R.L.; Shearen, J.G.; Scanlon, E.F. 1983: T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responses Cancer Detection and Prevention 6(1-2): 111-118
Fujimoto, S.; Greene, M.I.; Sehon, A.H. 1976: Regulation of the immune response to tumor antigens. II. the nature of immunosuppressor cells in tumor-bearing hosts Journal of Immunology 116(3): 800-806
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Carter, R.H.; Drebin, J.A.; Schatten, S.; Perry, L.L.; Greene, M.I. 1983: Regulation of the immune response to tumor antigens. IX. in vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen Journal of Immunology 130(2): 997-1002
Kachko, A.V.; Sviatchenko, V.A.; Ternovoĭ, V.A.; Kiselev, N.N.; Sorokin, A.V.; Kiselev, S.L.; Georgiev, G.P.; Netesov, S.V. 2003: Variants of adenovirus type 5 with deletions in early genes: ability for selective replication in p53-defective human tumor cells Molekuliarnaia Biologiia 37(5): 868-875
Rossowska, J.; Pajtasz-Piasecka, E.; Szyda, A.; Zietara, N.; Duś, D. 2007: Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response Folia Histochemica et Cytobiologica 45(4): 349-355
Mizushima, Y.; Sendo, F.; Miyake, T.; Kobayashi, H. 1981: Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan Journal of the National Cancer Institute 66(4): 659-665
Guillaume, T.; Sekhavat, M.; Rubinstein, D.B.; Hamdan, O.; Leblanc, P.; Symann, M.L. 1994: Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Research 54(14): 3800-3807
Abdou, N.I. 1982: Immune deficiency states--evaluation and management Journal of the Kansas Medical Society 83(5): 249-251; 260
1982: Update on acquired immune deficiency syndrome (AIDS)--United States Mmwr. Morbidity and Mortality Weekly Report 31(37): 507-8 513-4
Al'perina, E.L.; Gevorgian, M.M. 2010: Functional interplay of dopamine D1 and D2 receptors in the immune response control in different psychoemotional states Eksperimental'naia i Klinicheskaia Farmakologiia 73(6): 2-4
Wu, X.-F.; Wang, J.; Li, Y. 2013: Intervention of immune 1 combined HAART on immune function in patients with HIV/AIDS reconstruction Zhongguo Zhong Yao Za Zhi 38(15): 2453-2457